About: Immunogenicity of a killed Leishmania vaccine with saponin adjuvant in dogs

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Immunogenicity of a killed Leishmania vaccine with saponin adjuvant in dogs Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Immunogenicity of a killed Leishmania vaccine with saponin adjuvant in dogs
Creator	Corrêa-Oliveira, Rodrigo Teixeira-Carvalho, Andréa Aguiar-Soares, Oliveira Cosme, Luiz Das, Nádia De Lana, Marta Dian, Rodrigo Giunchetti, Rodolfo Lisboa Mota E Castro, Luciana Malaquias, Cotta Martins-Filho, Assis Mendes Roatt, Bruno Moreira, Dores Reis, Alexandre Vitoriano De Souza, Juliana
topic	covid:e10a3c96080f79b0406b3f938edd28236ab6b439#this
Source	Elsevier; Medline; PMC
abstract	Abstract Cellular and humoral immune responses of dogs to a candidate vaccine, composed of Leishmania braziliensis promastigote protein plus saponin as adjuvant, have been investigated as a pre-requisite to understanding the mechanisms of immunogenicity against canine visceral leishmaniasis (CVL). The candidate vaccine elicited strong antigenicity related to the increases of anti-Leishmania IgG isotypes, together with higher levels of lymphocytes, particularly of circulating CD8+ T-lymphocytes and Leishmania chagasi antigen-specific CD8+ T-lymphocytes. As indicated by the intense cell proliferation and increased nitric oxide production during in vitro stimulation by L. chagasi soluble antigens, the candidate vaccine elicited an immune activation status potentially compatible with effective control of the etiological agent of CVL.
has issue date	2007-11-01(xsd:dateTime)
bibo:doi	10.1016/j.vaccine.2007.08.009
bibo:pmid	17913311
has license	els-covid
sha1sum (hex)	e10a3c96080f79b0406b3f938edd28236ab6b439
schema:url	https://doi.org/10.1016/j.vaccine.2007.08.009
resource representing a document's title	Immunogenicity of a killed Leishmania vaccine with saponin adjuvant in dogs
has PubMed Central identifier	PMC7115514
has PubMed identifier	17913311
schema:publication	Vaccine
resource representing a document's body	covid:e10a3c96080f79b0406b3f938edd28236ab6b439#body_text
is http://vocab.deri.ie/void#inDataset of	https://covidontheweb.inria.fr:4443/about/id/http/ns.inria.fr/covid19/e10a3c96080f79b0406b3f938edd28236ab6b439
is schema:about of	named entity 'levels' named entity 'T-lymphocytes' named entity 'CIRCULATING' named entity 'STIMULATION' named entity 'ELICITED' named entity 'PROMASTIGOTE' named entity 'STRONG' named entity 'LYMPHOCYTES' named entity 'PROTEIN ' named entity 'COMPOSED OF' named entity 'LEISHMANIA BRAZILIENSIS' named entity 'DOGS' named entity 'ANTIGENS' named entity 'INCREASED' named entity 'COMPATIBLE WITH' named entity 'STATUS' named entity 'REQUISITE' named entity 'SAPONIN' named entity 'INCREASES' named entity 'CONTROL' named entity 'HIGHER' named entity 'INVESTIGATED' named entity 'LEVELS' covid:arg/e10a3c96080f79b0406b3f938edd28236ab6b439 named entity 'ADJUVANT' named entity 'CVL' named entity 'MECHANISMS' named entity 'KILLED' named entity 'DOGS' named entity 'CD8' named entity 'ANTIGEN' named entity 'EFFECTIVE' named entity 'SPECIFIC' named entity 'HAVE' named entity 'IN VITRO' named entity 'ANTIGENICITY' named entity 'CELLULAR' named entity 'PRE' named entity 'IMMUNOGENICITY' named entity 'IMMUNE ACTIVATION' named entity 'CELL PROLIFERATION' named entity 'INTENSE' named entity 'VACCINE' named entity 'LEISHMANIA IGG' named entity 'ADJUVANT' named entity 'T-LYMPHOCYTES' named entity 'RELATED' named entity 'NITRIC OXIDE PRODUCTION' named entity 'UNDERSTANDING' named entity 'SOLUBLE' named entity 'CANINE VISCERAL LEISHMANIASIS' named entity 'INDICATED' named entity 'LEISHMANIA CHAGASI' named entity 'SAPONIN' named entity 'CANDIDATE' named entity 'IMMUNE RESPONSES' named entity 'AGENT' named entity 'IMMUNOGENICITY' named entity 'LEISHMANIA VACCINE' named entity 'ISOTYPES' named entity 'antigenicity' named entity 'vaccine' named entity 'strong' named entity 'soluble' named entity 'cell proliferation'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software